HUNTIAM

Trial of the Combined Use of Thiamine and Biotin in Patients With Huntington's Disease

Phase 2 study testing thiamine to assess its safety and tolerability in people with Huntington's disease.

RecruitingPhase 2DrugClinicalTrials.govTreatment trial
  • ClinicalTrials.gov has not been updated recently (updated 25 Feb 2025), so this status may be out of date
  • EU recruitment has ended
Recruiting in: Madrid, San Sebastián, Seville, Spain
Preparing a short plain-English summary.

Fenix helps people discover research. It does not provide medical advice or determine eligibility.